関連する実験動画
Updated: Oct 9, 2026
10:53
Ultrasonic Assessment of Myocardial Microstructure
Published on: January 14, 2014
主要高血圧におけるプロコラーゲンペプチドの血清濃度の上昇. 心臓の変異との関連
1Department of Internal Medicine, School of Medicine, University of Navarra, Pamplona, Spain.
Circulation
|March 1, 1995
まとめ
血清プロコラーゲンペプチド (PIIIPとPIP) は,本質的な高血圧におけるコラーゲン合成の増加を示しています. リシノプリルによる治療は,これらのマーカーを正常化し,心臓機能を改善し,高血圧性心疾患の診断価値を示唆した.
科学分野:
- 心臓病学 心臓病学
- バイオケミストリー バイオケミストリー
- ネフロロジーはネフロロジーを用います.
背景:
- プロコラーゲン型IIIアミノ端末ペプチド (PIIIP) とプロコラーゲン型Iカルボキシ端末ペプチド (PIP) の血清濃度は,コラーゲン合成を示す可能性があります.
- エッセンシャル高血圧は,心筋コラーゲンの蓄積と関連しており,左心室の解剖学と機能に影響します.
研究 の 目的:
- 血清PIIIPとPIPを測定することによって,エッセンシャル高血圧における線維性活性を評価する.
- 血清PIIIPとPIPレベルと高血圧患者の左心室のパラメータとの関係を評価する.
主な方法:
- 血清PIIIPとPIPの測定のための放射性免疫測定法.
- 左心室の評価と不律症の分類のためのエコーカルジオグラフィと外出心電図モニタリング.
- この研究には,これまで治療を受けていない高血圧患者50人,対照患者30人が参加し,リシノプリル治療後のフォローアップが行われました.
主要な成果:
- 高血圧患者は,対照群と比較して血清PIIIPとPIPの上昇を示した.
- 血清PIIIPは,下痢性充填と逆相関し,PIPは,左心室質量指数と心室不律症と直接相関した.
- リジノプリル治療は血圧を正常化し,心臓機能を改善し,血清PIIIPとPIPレベルを低下させた.
結論:
- III型とI型コラーゲンの組織合成は,本質的な高血圧で上昇し,リシノプリルに反応する.
- 血清のPIIIPおよびPIPレベルは,高血圧における心臓の構造的および機能的変化と相関しています.
- 血清プロコラーゲンペプチドは,動脈高血圧における心筋線維症の間接的な診断マーカーとして機能する可能性があります.
さらに関連する動画
関連する概念動画
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...